EcoDrugPlus


Synonyms	Ancloximex Animexan DAC N-055 Dac n-055 Dermazoon Desopur Immunokine Macrokine Oxoferin Oxomexan Oxovasin Oxovir Oxoviron Tetrachlorodecaoxide WF-10
Status
Molecule Category	Free-form
UNII	549BT7IE1Q
EPA CompTox	DTXSID40238840

Synonyms

Ancloximex

Animexan

DAC N-055

Dac n-055

Dermazoon

Desopur

Immunokine

Macrokine

Oxoferin

Oxomexan

Oxovasin

Oxovir

Oxoviron

Tetrachlorodecaoxide

WF-10

Status

Molecule Category

Free-form

UNII

549BT7IE1Q

EPA CompTox

DTXSID40238840


Active Pharmaceutical Ingredients Bioactive chemicals	Exact Similarity SubStructure	Threshold (%) >= 70


InChI Key	IVFGWWGNVIZDAS-UHFFFAOYSA-N
Smiles	O=O.[O-][Cl+]O.[O-][Cl+]O.[O-][Cl+]O.[O-][Cl+]O
InChI	InChI=1S/4ClHO2.O2/c42-1-3;1-2/h4(H,2,3);

InChI Key

IVFGWWGNVIZDAS-UHFFFAOYSA-N

Smiles

O=O.[O-][Cl+]O.[O-][Cl+]O.[O-][Cl+]O.[O-][Cl+]O

InChI

InChI=1S/4ClHO2.O2/c4*2-1-3;1-2/h4*(H,2,3);

Property Name	Value
Molecular Formula	H2Cl4O11-4
Molecular Weight	319.82
AlogP	None
Hydrogen Bond Acceptor	None
Hydrogen Bond Donor	None
Number of Rotational Bond	None
Polar Surface Area	None
Molecular species	None
Aromatic Rings	None
Heavy Atoms	None

Property Name

Value

Molecular Formula

H2Cl4O11-4

Molecular Weight

319.82

AlogP

None

Hydrogen Bond Acceptor

None

Hydrogen Bond Donor

None

Number of Rotational Bond

None

Polar Surface Area

None

Molecular species

None

Aromatic Rings

None

Heavy Atoms

None

Resources	Reference
ChEMBL	CHEMBL3707387
FDA SRS	549BT7IE1Q
ChEMBL	CHEMBL4299960
FDA SRS	549BT7IE1Q

Resources

Reference

ChEMBL

FDA SRS

ChEMBL

FDA SRS


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

TETRACHLORODECAOXIDE

Structure

Physicochemical Descriptors

Cross References